|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Cetuximab, a Monoclonal Antibody
Targeting the Epidermal Growth Factor Receptor, in Combination
with Gemcitabine for Advanced Pancreatic Cancer: A Multicenter
Phase II Trial J Clin Oncol. 2004 Jul 1;22(13):2610-6. PMID: 15226328
|
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |